Zacks.com on MSN

WGS, Zevra Partner to Launch Genetic Testing for Niemann-Pick Type C

GeneDx Holdings WGS announced a sponsored genetic testing program with Zevra Therapeutics to improve diagnosis for patients suspected of having Niemann-Pick Disease Type C (NPC), a rare and ...